This was just posted from an inquiry to Symtomax a
Post# of 295
(Total Views: 384)
Posted On: 01/14/2020 1:40:36 PM
This was just posted from an inquiry to Symtomax about the relationship with GCAN! It is outstanding!!!!
Quote:
Good afternoon xxxxxxxxxxx,
Thank you for your email enquiry about GCAN. Symtomax have a JV partnership in place with GCAN to be distributor of their oral patch which we have white labelled and will be launching as the Symtomax Oral Tab. Our agreement terms are strictly private and confidential between our companies. However I would urge you as an investor of GCAN and not Symtomax to contact them and direct any questions you have to them. Symtomax have an ongoing PR campaign to promote this product and we believe this will be hugely successful which I presume all share holders of GCAN will benefit from, however that a conversation you must have with them. Again I want to re iterate we can not disclose any sensitive corporate information which has been agreed under signed NDA.
Many thanks
Paul Segal
Chairman & Co-Founder
Praça Bom Sucesso, Edifício Península nº127/131. 8ºandar, Escritório 801, 4150-146 Porto, Portugal
phone: +351 937019489
email: paul@symtomax.com
web: www.symtomax.com
(0)
(0)Greater Cannabis Co Inc. (GCAN) Stock Research Links
Scroll down for more posts ▼